Jefferies Financial Group’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,000
Closed -$63.3K 1663
2024
Q2
$63.3K Buy
+5,000
New +$50.3K ﹤0.01% 1312
2023
Q2
Sell
-120,300
Closed -$834K 1909
2023
Q1
$834K Buy
120,300
+35,700
+42% +$328K 0.01% 955
2022
Q4
$870K Buy
+84,600
New +$1.49M 0.01% 909

Other funds holding NVAX

Jefferies Financial Group's NVAX Position: Q1 2026 in Review

Jefferies Financial Group opened a new position in Novavax (NVAX) in Q1 2026: 673,120 shares worth $5.48M. The stake represents 0.04% of the portfolio and ranks #327 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in NVAX as recently as Q4 2024.

Jefferies Financial Group first reported a position in NVAX in Q4 2022 and has held it in 8 quarters since. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Jefferies Financial Group held 673,120 shares of Novavax worth $5.48M as of Q1 2026.
  • Novavax was a new Jefferies Financial Group position in Q1 2026.
  • Novavax made up 0.04% of Jefferies Financial Group's portfolio in Q1 2026, its #327 holding.
  • Jefferies Financial Group first reported a position in Novavax in Q4 2022 and has held it in 8 quarters since.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.